JP2004528334A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004528334A5 JP2004528334A5 JP2002583393A JP2002583393A JP2004528334A5 JP 2004528334 A5 JP2004528334 A5 JP 2004528334A5 JP 2002583393 A JP2002583393 A JP 2002583393A JP 2002583393 A JP2002583393 A JP 2002583393A JP 2004528334 A5 JP2004528334 A5 JP 2004528334A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- group
- moiety
- methyl
- heteroaryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0101387A SE0101387D0 (sv) | 2001-04-20 | 2001-04-20 | Novel compounds |
| PCT/SE2002/000769 WO2002085866A1 (en) | 2001-04-20 | 2002-04-18 | Novel compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004528334A JP2004528334A (ja) | 2004-09-16 |
| JP2004528334A5 true JP2004528334A5 (https=) | 2005-12-22 |
Family
ID=20283822
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002583393A Pending JP2004528334A (ja) | 2001-04-20 | 2002-04-18 | 新規な化合物 |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US7030139B2 (https=) |
| EP (1) | EP1390350A1 (https=) |
| JP (1) | JP2004528334A (https=) |
| KR (1) | KR20040022421A (https=) |
| CN (1) | CN1250531C (https=) |
| AR (1) | AR035959A1 (https=) |
| BG (1) | BG108271A (https=) |
| BR (1) | BR0208907A (https=) |
| CA (1) | CA2444381A1 (https=) |
| CZ (1) | CZ20032833A3 (https=) |
| EE (1) | EE200300524A (https=) |
| HU (1) | HUP0303825A3 (https=) |
| IL (1) | IL158142A0 (https=) |
| IS (1) | IS6971A (https=) |
| MX (1) | MXPA03009558A (https=) |
| MY (1) | MY134568A (https=) |
| NO (1) | NO20034665L (https=) |
| NZ (1) | NZ528403A (https=) |
| PL (1) | PL366517A1 (https=) |
| RU (1) | RU2312864C2 (https=) |
| SE (1) | SE0101387D0 (https=) |
| SK (1) | SK13032003A3 (https=) |
| UA (1) | UA76743C2 (https=) |
| WO (1) | WO2002085866A1 (https=) |
| ZA (1) | ZA200307752B (https=) |
Families Citing this family (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003217961B2 (en) | 2002-03-08 | 2008-02-28 | Signal Pharmaceuticals, Llc | Combination therapy for treating, preventing or managing proliferative disorders and cancers |
| SE0203070D0 (en) * | 2002-10-16 | 2002-10-16 | Astrazeneca Ab | Novel compounds |
| CA2518318A1 (en) * | 2003-03-17 | 2004-09-30 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
| SE0300908D0 (sv) * | 2003-03-31 | 2003-03-31 | Astrazeneca Ab | Azaindole derivatives, preparations thereof, uses thereof and compositions containing them |
| SE0301446D0 (sv) * | 2003-05-16 | 2003-05-16 | Astrazeneca Ab | New Compounds |
| SE0301699D0 (sv) * | 2003-06-10 | 2003-06-10 | Astrazeneca Ab | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| SE0301698D0 (sv) * | 2003-06-10 | 2003-06-10 | Astrazeneca Ab | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| SE0301701D0 (sv) * | 2003-06-10 | 2003-06-10 | Astrazeneca Ab | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| BRPI0411740A (pt) | 2003-06-26 | 2006-05-23 | Takeda Pharmaceutical | modulador do receptor de canabinóide, composto, pró-droga, droga, método para prevenir ou tratar uma doença ou condição, uso de um composto, e, método para preparar um composto |
| US7157471B2 (en) * | 2003-08-25 | 2007-01-02 | Boehringer Ingelheim International Gmbh | Haloalkyl- and piperidine-substituted benzimidazole-derivatives |
| WO2005021547A2 (en) * | 2003-08-28 | 2005-03-10 | Pharmaxis Pty Ltd. | Heterocyclic cannabinoid cb2 receptor antagonists |
| SE0302571D0 (sv) * | 2003-09-26 | 2003-09-26 | Astrazeneca Ab | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| SE0302572D0 (sv) * | 2003-09-26 | 2003-09-26 | Astrazeneca Ab | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| SE0302573D0 (sv) * | 2003-09-26 | 2003-09-26 | Astrazeneca Ab | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| SE0302570D0 (sv) * | 2003-09-26 | 2003-09-26 | Astrazeneca Ab | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| EP1675822A2 (en) * | 2003-10-16 | 2006-07-05 | Cara Therapeutics, Inc. | Amide or thioamide derivatives and their use in the treatment of pain |
| WO2006033629A1 (en) * | 2004-09-24 | 2006-03-30 | Astrazeneca Ab | Benzimidazole derivatives and their use as cannabinoid receptor ligands |
| WO2006033627A1 (en) * | 2004-09-24 | 2006-03-30 | Astrazeneca Ab | Compounds, compositions containing them, preparation thereof and uses thereof iiii |
| WO2006033630A1 (en) * | 2004-09-24 | 2006-03-30 | Astrazeneca Ab | Compounds, compositions containing them, preparation thereof and uses thereof iii |
| EP1797076A1 (en) * | 2004-09-24 | 2007-06-20 | AstraZeneca AB | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| EP1797070A1 (en) * | 2004-09-24 | 2007-06-20 | AstraZeneca AB | Compounds, compositions containing them, preparations thereof and uses thereof ii |
| WO2006033631A1 (en) * | 2004-09-24 | 2006-03-30 | Astrazeneca Ab | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof i |
| UA87327C2 (ru) * | 2004-09-24 | 2009-07-10 | Астразенека Аб | Производные бензимидазола, композиция, которая их содержит, их получение и применение |
| MX2007003105A (es) | 2004-09-24 | 2007-06-07 | Aztrazeneca Ab | Derivados de bencimidazol, composiciones que los contienen, sus preparaciones y sus usos i. |
| WO2006033632A1 (en) * | 2004-09-24 | 2006-03-30 | Astrazeneca Ab | Benzimidazole derivatives and their use as cannabinoid receptor ligands I |
| AU2005298986A1 (en) * | 2004-10-27 | 2006-05-04 | F. Hoffmann-La Roche Ag | New indole or benzimidazole derivatives |
| MX2007005290A (es) | 2004-11-02 | 2007-07-09 | Pfizer | Derivados de sulfonilbencimidazol. |
| SE0402762D0 (sv) * | 2004-11-11 | 2004-11-11 | Astrazeneca Ab | Indazole sulphonamide derivatives |
| SE0402763D0 (sv) * | 2004-11-11 | 2004-11-11 | Astrazeneca Ab | Nitro indazole derivatives |
| EP1861377B1 (en) * | 2005-03-15 | 2010-12-29 | Pfizer, Inc. | Benzimidazolone derivatives as cb2 receptor ligands |
| CA2602368A1 (en) | 2005-04-28 | 2006-11-02 | Ferring B.V. | Use of novel compounds for ibd treatment |
| TW200736227A (en) | 2005-12-23 | 2007-10-01 | Astrazeneca Ab | New compounds III |
| WO2007091950A1 (en) * | 2006-02-07 | 2007-08-16 | Astrazeneca Ab | Benzimidazoles and imidazopyridines useful in the treatment of diseases or disorders associated with cannabinoid receptor 2 (cb2) such as pain |
| EP1994011B1 (en) * | 2006-03-06 | 2010-10-13 | RaQualia Pharma Inc | Sulfonyl benzimidazole derivatives |
| TW200745049A (en) * | 2006-03-23 | 2007-12-16 | Astrazeneca Ab | New crystalline forms |
| TW200808769A (en) * | 2006-04-18 | 2008-02-16 | Astrazeneca Ab | Therapeutic compounds |
| TW200808772A (en) * | 2006-06-13 | 2008-02-16 | Astrazeneca Ab | Therapeutic compounds |
| PT2081572E (pt) * | 2006-07-04 | 2010-05-17 | Janssen Pharmaceutica Nv | Agonistas de canabinóides de benzimidazolo com um grupo heterocíclico substituído |
| TWI433839B (zh) | 2006-08-11 | 2014-04-11 | Neomed Inst | 新穎的苯并咪唑衍生物290 |
| FR2907784B1 (fr) * | 2006-10-27 | 2009-02-13 | Sod Conseils Rech Applic | Derives phenyliques et leur utilisation comme medicament |
| WO2009116074A2 (en) * | 2008-02-13 | 2009-09-24 | Cadila Healthcare Limited | Substituted benzimidazoles as cannabinoid modulator |
| US20120277296A1 (en) | 2009-07-23 | 2012-11-01 | Sophie Lotersztajn | Selective CB2 Receptor Agonists for Use in the Prevention or Treatment of Alcoholic Liver Disease |
| US20110086853A1 (en) * | 2009-10-08 | 2011-04-14 | William Brown | Therapeutic Compounds |
| US8759535B2 (en) * | 2010-02-18 | 2014-06-24 | High Point Pharmaceuticals, Llc | Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof |
| WO2011103018A1 (en) | 2010-02-18 | 2011-08-25 | High Point Pharmaceuticals, Llc | Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof |
| EP2734517B1 (en) | 2011-07-18 | 2017-08-30 | Merck Patent GmbH | Benzamides |
| CN102977056B (zh) * | 2012-11-28 | 2014-11-26 | 深圳万乐药业有限公司 | N-苄氧羰基-3-氟-4-吗啉基苯胺的合成方法 |
| WO2016089648A1 (en) | 2014-12-01 | 2016-06-09 | Vtv Therapeutics Llc | Bach 1 inhibitors in combination with nrf2 activators and pharmaceutical compositions thereof |
| CN107531679B (zh) * | 2016-03-18 | 2021-07-02 | 江苏恒瑞医药股份有限公司 | 芳香酰胺类衍生物、其制备方法及其在医药上的应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2945044A (en) * | 1957-07-12 | 1960-07-12 | Ciba Pharm Prod Inc | Certain 1-(diethyl-aminoethyl), 5-amino, 2-benzyl or substituted benzyl, benzimidazoles |
| FR1481049A (fr) | 1965-11-25 | 1967-05-19 | France Ministre Des Armees | Nouveaux dialkylaminoalkyl-1 p-alkoxyphényl alkyl-2 benzimidazoles 5-substitués |
| US5620978A (en) * | 1994-01-03 | 1997-04-15 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon, Eugene Oregon | 8-aza, 6-aza and 6,8-diaza-1,4-dihydroquinoxaline-2,3-diones and the use thereof as antagonists for the glycine/NMDA receptor |
| FI964908L (fi) * | 1994-06-10 | 1996-12-09 | Byk Gulden Lomberg Chem Fab | Helicobacter-bakteerien torjuntaan tarkoitetut tiopyridiinit |
| SE0203070D0 (en) * | 2002-10-16 | 2002-10-16 | Astrazeneca Ab | Novel compounds |
-
2001
- 2001-04-20 SE SE0101387A patent/SE0101387D0/xx unknown
-
2002
- 2002-04-18 MX MXPA03009558A patent/MXPA03009558A/es active IP Right Grant
- 2002-04-18 SK SK1303-2003A patent/SK13032003A3/sk not_active Application Discontinuation
- 2002-04-18 BR BR0208907-6A patent/BR0208907A/pt not_active IP Right Cessation
- 2002-04-18 HU HU0303825A patent/HUP0303825A3/hu unknown
- 2002-04-18 KR KR10-2003-7013622A patent/KR20040022421A/ko not_active Ceased
- 2002-04-18 CN CNB028085779A patent/CN1250531C/zh not_active Expired - Fee Related
- 2002-04-18 CA CA002444381A patent/CA2444381A1/en not_active Abandoned
- 2002-04-18 RU RU2003129638/04A patent/RU2312864C2/ru not_active IP Right Cessation
- 2002-04-18 UA UA2003108942A patent/UA76743C2/uk unknown
- 2002-04-18 CZ CZ20032833A patent/CZ20032833A3/cs unknown
- 2002-04-18 US US10/474,549 patent/US7030139B2/en not_active Expired - Fee Related
- 2002-04-18 EP EP02764120A patent/EP1390350A1/en not_active Withdrawn
- 2002-04-18 IL IL15814202A patent/IL158142A0/xx unknown
- 2002-04-18 MY MYPI20021423A patent/MY134568A/en unknown
- 2002-04-18 NZ NZ528403A patent/NZ528403A/en unknown
- 2002-04-18 JP JP2002583393A patent/JP2004528334A/ja active Pending
- 2002-04-18 EE EEP200300524A patent/EE200300524A/xx unknown
- 2002-04-18 PL PL02366517A patent/PL366517A1/xx not_active Application Discontinuation
- 2002-04-18 WO PCT/SE2002/000769 patent/WO2002085866A1/en not_active Ceased
- 2002-04-19 AR ARP020101441A patent/AR035959A1/es not_active Application Discontinuation
-
2003
- 2003-09-29 IS IS6971A patent/IS6971A/is unknown
- 2003-10-03 ZA ZA200307752A patent/ZA200307752B/en unknown
- 2003-10-14 BG BG108271A patent/BG108271A/bg unknown
- 2003-10-17 NO NO20034665A patent/NO20034665L/no not_active Application Discontinuation
-
2006
- 2006-01-04 US US11/325,124 patent/US20060135554A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004528334A5 (https=) | ||
| RU2003129638A (ru) | Новые соединения | |
| AU2019283921B2 (en) | Indole carboxamide compounds useful as kinase inhibitors | |
| JP2019517487A5 (https=) | ||
| CN1152870A (zh) | 杂环化合物作为多巴胺d3配位体的用途 | |
| JP2005538062A5 (https=) | ||
| IN2015DN01132A (https=) | ||
| US9737522B2 (en) | NMDA receptor modulators and uses related thereto | |
| JP2009526830A5 (https=) | ||
| JP2006143737A5 (https=) | ||
| JP2006513265A5 (https=) | ||
| JP2010530431A5 (https=) | ||
| JP2017533968A5 (https=) | ||
| JP2008513498A5 (https=) | ||
| JP2004518723A5 (https=) | ||
| WO2005077950A3 (en) | Medicaments with hm74a receptor activity | |
| JP2011524422A5 (https=) | ||
| JP2005501120A5 (https=) | ||
| CA2568608A1 (en) | Six membered amino-amide derivatives as angiogenesis inhibitors | |
| WO2005047279A8 (en) | Substituted nitrogen-containing six-membered amino-heterocycles as vanilloid-1 receptor antagonists for treating pain | |
| JPH11193282A5 (https=) | ||
| RU2005114021A (ru) | Производные имидазола и их применение в качестве периферически-селективных ингибиторов дофамин-бета-гидролазы | |
| CA2504907A1 (en) | Indoles useful in the treatment of androgen-receptor related diseases | |
| CA2564442A1 (en) | 2-pyridyl substituted imidazoles as alk5 and/or alk4 inhibitors | |
| ZA200303599B (en) | Piperazinylpyrazine compounds as agonist or antagonist of serotonin 5HT-2 receptor. |